Mizuho Securities Downgrades Exact Sciences (EXAS) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
Exact Sciences (EXAS) Tops Q1 EPS by 3c
May 3, 2016 7:32 AM EDTExact Sciences (NASDAQ: EXAS) reported Q1 EPS of ($0.49), $0.03 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $14.8 million versus the consensus estimate of $14.83 million.
For earnings history and earnings-related data on Exact Sciences (EXAS) click here.
... More